Chronic resveratrol consumption prevents hypertension development altering electrophysiological currents and Ca2+ signaling in chromaffin cells from SHR rats

• Published in: Cellular signalling 2020-12, Vol.76, p.109811-109811, Article 109811
• Main Authors: Bomfim, Guilherme Henrique Souza, Musial, Diego Castro, Méndez-López, Iago, Jurkiewicz, Aron, Jurkiewicz, Neide Hyppolito, Padín, Juan Fernando, García, Antonio G.
• Format: Article
• Language: English
• Subjects: Ca2+ signaling; Chromaffin cells; Hypertension; Ionic currents; Resveratrol consumption; Spontaneously hypertensive rat
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2020.109811

Resveratrol (RESV) is one of the most abundant polyphenol-stilbene compounds found in red wine with well-established cardioprotective and antihypertensive effects. Hyperactivity of the sympathoadrenal axis seems to be one of the major contributing factors in the pathogenesis of human essential hypertension. Alterations in outward voltage-dependent potassium currents (IK) and inward voltage-dependent sodium (INa), calcium (ICa) and nicotinic (IACh) currents, CCs excitability, Ca2+ homeostasis, and catecholamine exocytosis were previously related to the hypertensive state. This raised the issue of whether in vivo long-term RESV treatment can directly act as a modulator of Ca2+ influx or a regulator of ion channel permeability in CCs. We monitored outward and inward currents, and cytosolic Ca2+ concentrations ([Ca2+]c) using different pharmacological approaches in CCs from normotensive (WKY) and hypertensive (SHR) animals chronically exposed to trans-RESV (50 mg/L/v.o, 28 days). The long-term RESV treatment prevented the increase of the systolic blood pressure (SBP) in SHR, without reversion of cardiac hypertrophy. We also found an increase of the outward IK, reduction in inward INa,ICa, and IACh, and the mitigation of [Ca2+]c overload in CCs from SHR at the end of RESV treatment. Our data revealed that electrophysiological alterations of the CCs and in its Ca2+ homeostasis are potential new targets related to the antihypertensive effects of long-term RESV treatment. [Display omitted] •The long-term resveratrol treatment prevented the increase of SBP in SHR;•Hyperactivity of the sympathoadrenal axis seems to be one of its main targets;•Electrophysiological and Ca2+ alterations are related to the antihypertensive effects of long-term resveratrol.